Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Colorcon
Merck
Dow
McKesson

Last Updated: July 1, 2022

CLINICAL TRIALS PROFILE FOR MOVIPREP


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Moviprep

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00312481 ↗ MOVIPREP® Versus PICOLAX® Pilot Study Completed Norgine Phase 2 2005-07-01 This will be a randomised, single-centre, single-blind, parallel-group, pilot study in patients undergoing colonoscopy. The primary objective is to evaluate the efficacy of MOVIPREP® versus PICOLAX® for gut cleansing prior to colonoscopy. The secondary objectives are to evaluate the safety, tolerability and acceptability of MOVIPREP versus PICOLAX for gut cleansing prior to colonoscopy.
NCT00322062 ↗ MOVIPREP® Versus NaP Pivotal Phase III Study Completed Norgine Phase 3 2002-04-01 The aim of the study is to compare a new 2 litre bowel cleansing product versus a sodium phosphate solution already on the market. Efficacy of each bowel preparation, safety and acceptability will be assessed.
NCT00389233 ↗ A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution Completed Norgine Phase 3 2002-06-01 The study was carried out as a randomised, single-blind, active-controlled, multi-centric, phase III study with two parallel treatment groups. The primary efficacy criterion was the frequency of effective gut cleansing in each of the two treatment groups (grade A or B "overall quality of gut cleansing" as judged by a blinded expert panel on the basis of videotapes recorded during the endoscopic procedure).
NCT00427089 ↗ Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening Completed Norgine Phase 3 2004-09-01 To compare the efficacy, acceptability and safety of the new 2 liter gut cleansing solution (Moviprep) and NaP preparation in routine colon cleansing prior to tumor screening colonoscopies
NCT00605228 ↗ A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation Completed International Clinical Trials Association Phase 4 2007-05-01 Primary: - To demonstrate the superiority of Moviprep® versus Colopeg® in gut cleansing prior to colonoscopy. Secondary: - To assess the safety of Moviprep® versus Colopeg®. - To assess acceptability of Moviprep® versus Colopeg®.
NCT00605228 ↗ A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation Completed Norgine Phase 4 2007-05-01 Primary: - To demonstrate the superiority of Moviprep® versus Colopeg® in gut cleansing prior to colonoscopy. Secondary: - To assess the safety of Moviprep® versus Colopeg®. - To assess acceptability of Moviprep® versus Colopeg®.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Moviprep

Condition Name

Condition Name for Moviprep
Intervention Trials
Colonoscopy 8
Colorectal Cancer 5
Irritable Bowel Syndrome Characterized by Constipation 2
Colon Cancer 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Moviprep
Intervention Trials
Colorectal Neoplasms 4
Colonic Neoplasms 3
Gastrointestinal Diseases 2
Colonic Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Moviprep

Trials by Country

Trials by Country for Moviprep
Location Trials
Italy 20
United States 18
Germany 13
United Kingdom 6
France 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Moviprep
Location Trials
Indiana 2
Arizona 2
Illinois 2
Pennsylvania 2
Connecticut 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Moviprep

Clinical Trial Phase

Clinical Trial Phase for Moviprep
Clinical Trial Phase Trials
Phase 4 10
Phase 3 7
Phase 2/Phase 3 1
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Moviprep
Clinical Trial Phase Trials
Completed 26
Not yet recruiting 4
Unknown status 4
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Moviprep

Sponsor Name

Sponsor Name for Moviprep
Sponsor Trials
Norgine 12
Thomas Jefferson University 2
Arizona State University 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Moviprep
Sponsor Trials
Other 33
Industry 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Dow
Boehringer Ingelheim
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.